Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2001Journal of Viral Hepatitis

Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

John G. McHutchisonJohn G. McHutchisonHuman Genome Sciences (United States)JSJavaid A. ShadNaval Hospital JacksonvilleSGStuart C. GordonHenry Ford Health System

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

McHutchison et al. (2001) studied this question.

synapsesocial.com/papers/6a20e0b534bef10fdaeb187dhttps://doi.org/10.1046/j.1365-2893.2001.00312.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?2000 · 370 citations
  2. 2Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection1999 · 3 citations
  3. 3Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon-α Therapy1997 · 561 citations
  4. 4Correlation of serum HCV RNA and alanine aminotransferase levels in chronic hepatitis C patients during treatment with ribavirin1994 · 51 citations
  5. 5Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison1997 · 124 citations